Novel Cellular Factors Restricting Viral Membrane Fusion
Novel Cellular Factors Restricting Viral Membrane Fusion
批准号:
8605170
负责人:
Shan-Lu Liu
金额:
$19.19万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-15 至 2015-12-31
关键词:
Academic Medical CentersAntiviral AgentsAntiviral TherapyBiological AssayBiologyCell Surface ProteinsCell fusionCell membraneCell physiologyCellsCollaborationsDevelopmentEndocytosisEventFUS-1 ProteinFamilyFertilizationFluorescenceFutureGenesGrowthHIV-1HemagglutininHumanIFITM1 geneImaging TechniquesInfectionInfluenzaInfluenza A virusIntegral Membrane ProteinInterferonsInvestigationLabelLeadLifeLipidsLiposomesMembraneMembrane FusionMolecularMorbidity - disease ratePeptidesPlayProcessRespiratory DiaphragmRoleRuptureSeriesStagingTestingTherapeuticTissuesVesicleViralViral Fusion ProteinsVirionVirusVirus Diseasesanalogdesignfluidityforestin vivoinsightlaurdanmembermortalitynovelparticlepreventpublic health relevancereconstitutionresearch studysynthetic peptidetomographyvesicular stomatitis virus G protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In this R21 application, we aim to determine how the newly identified cellular restriction factors, known as interferon-inducible transmembrane (IFITM) proteins, modulate viral membrane fusion and entry, and in doing so, aid the development of novel antiviral therapeutics. The specific aims of this proposal are as follows. Aim 1: Test the hypothesis that IFITM proteins inhibit membrane fusion by preventing hemifusion. We will perform cell-cell and virion-cell fusion assays, including the use of single viral particle imaging technique, to determine the stages of the viral membrane fusion process blocked by IFITM proteins. Lipid analogs that modulate distinct stages of the membrane fusion process will be applied. We will explore the possibility that IFITM proteins restrict membrane fusion induced by cellular and developmental fusogens. Aim 2: Test the hypothesis that expression of IFITM proteins changes the lipid order of cell membranes and confers positive spontaneous curvature. We will perform fluorescence membrane labeling experiments to test the hypothesis that IFITM proteins cause the cell membrane to be more ordered, resulting in reduced fluidity and therefore less competency for fusion. We will also determine the effect of IFITM proteins on membrane curvature by reconstituting artificial liposomes with synthetic peptides corresponding to the functional domains in IFITM proteins. Cryo-EM tomography will be applied to directly visualize the curvature changes upon insertion of IFITM peptides into the artificial liposome vesicles. IFITM proteins are the first and so far only cellular restriction fators that are known to restrict viral membrane fusion and entry. Results from the proposed studies will provide novel insight as to how IFITM proteins restrict viral membrane fusion. These results will guide future comprehensive investigations into the biology of IFITM proteins, as well as their
critical roles in restricting viral entry and infection.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef
-
批准号:10242695
-
项目类别:
-
资助金额:$33.15万
-
财政年份:2018
-
负责人:Shan-Lu Liu
-
依托单位:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
-
批准号:9376203
-
项目类别:
-
资助金额:$36.3万
-
财政年份:2017
-
负责人:Shan-Lu Liu
-
依托单位:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
-
批准号:8991472
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2014
-
负责人:Shan-Lu Liu
-
依托单位:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
-
批准号:8730947
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2014
-
负责人:Shan-Lu Liu
-
依托单位:
Inhibition of Ebolavirus Entry by IFITM2 Protein
-
批准号:8702561
-
项目类别:
-
资助金额:$22.61万
-
财政年份:2014
-
负责人:Shan-Lu Liu
-
依托单位:
Restriction of Viral Membrane Fusion and Entry by IFITM Proteins
-
批准号:8896142
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2014
-
负责人:Shan-Lu Liu
-
依托单位:
Novel Cellular Factors Restricting Viral Membrane Fusion
-
批准号:8492736
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2013
-
负责人:Shan-Lu Liu
-
依托单位:
海外基金